Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

No End In Sight: Pharma Companies Continue To Face Government Probes

15 Aug 2011

Related Content

Lilly, Novo Nordisk Under Government Investigation For Promotion Of Their Diabetes Drugs

22 Feb 2011

Cephalon's Double Trouble: DoJ Probes Treanda Marketing, Clinical Trial Data

11 Jul 2011

Medco Health Solutions Faces Second DoJ Probe In Five Years; Latest Involves AstraZeneca

26 Jul 2011

AstraZeneca Faces Government Probe Of Synagis Sales And Marketing

01 Aug 2011

Bundling of Wyeth Protonix Sales to Hospitals Tied to Medicaid Fraud, DoJ Says

25 May 2009

GSK Ups Legal Reserve, May Break Pfizer's Settlement Record

18 Jan 2011

Rapamune Whistleblower Suit Gets Jolt From Government Intervention

21 Sep 2010

Merck To Join Pfizer and Lilly At Top of DoJ Settlements Chart

08 Nov 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.